Supplementary Materials

Published: 13 December 2021| Version 1 | DOI: 10.17632/3rxp9t9jpb.1
Contributor:
Xiuzhi Wu

Description

Supplementary Materials for "A Multi-Center, Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study Evaluating Efficacy and Safety of Vunakizumab in Patients with Moderate-to-Severe Plaque Psoriasis"

Files

Categories

Clinical Trial, Psoriasis

License